Conversely, a recent study contradicted those findings, showing elevated GITR levels as well as PD-1 and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) levels in treatment-naïve chronic HBV patients and individuals with HBV-related hepatic failure [76]. The gene discussed is CTLA4; the disease is liver failure.